/MYTC.CN

MYTC.CN Stock - MyndTec Inc.

Q: What is the analyst price target for MYTC.CN?

Analyst price target information is not currently available for MYTC.CN.

Q: What is MYTC.CN's market cap?

Market capitalization information is not currently available for MYTC.CN.

Healthcare|Medical - Devices|CNQ

$0.02+0.00%

+$0.00 (+0.00%) • Dec 22

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

HOLD

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

100

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $0.02

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for MYTC.CN

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2020

FY2021

FY2022

FY2023

FY2024

← Swipe to see more →

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta-6.80

52W High$0.35

52W Low$0.01

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2024	FY2023	FY2022	FY2021	FY2020
Revenue	$111,434	$137,312	$255,801	$605,567	$162,634
Gross Profit	$4,856	$54,896	$67,444	$354,621	$67,044
Gross Margin	4.4%	40.0%	26.4%	58.6%	41.2%
Operating Income	$-1,226,719	$-1,594,433	$-2,017,321	$-2,742,184	$-1,620,498
Net Income	$-1,247,407	$-1,723,330	$-2,247,105	$-3,335,260	$-1,809,010
Net Margin	-1119.4%	-1255.0%	-878.5%	-550.8%	-1112.3%
EPS	$-0.05	$-0.07	$-0.11	$-0.15	$-0.08

Company Overview

MyndTec Inc., a medical technology company, researches, develops, and distributes therapies for individuals with paralysis due to stroke or spinal cord injury in Canada and the United States. Its flagship product is MyndMove, a non-invasive functional electrical stimulation-based intervention that uses neuroplasticity mechanisms to stimulate the development of new neural efferent and afferent pathways allowing patients to re-establish voluntary movement and improve independence in their activities of daily living, as well as offers trained therapists the ability to assist individuals affected with paralysis to enhance voluntary control of their limbs. The company offers MyndMove or MyndSearch devices to clinics and research institutions, as well as sells treatment supplies. It serves hospitals through direct sales, as well as a network of distributors. The company was formerly known as Simple Systems Inc. and changed its name to MyndTec Inc. in April 2013. MyndTec Inc. was incorporated in 2008 and is headquartered in Mississauga, Canada.

Visit Website